| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.18 | 0.008 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |